Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
American Journal of Surgery|January 22, 2008
Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinomaCraig Messick, Jeffrey M Hardacre, Michael F McGee, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 4, 2022
Medicaid expansion is associated with a higher likelihood of early diagnosis, resection, transplantation, and overall survival in patients with hepatocellular carcinomaMohamedraed Elshami, Richard Hoehn, Jonathan J Hue, et al.Journal of Surgical Oncology|January 5, 2021
A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: An analysis of the National Cancer DatabaseJonathan J Hue, Flavio G Rocha, John B Ammori, et al.Annals of Surgical Oncology|August 25, 2023
Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based StudyKavin Sugumar, Jonathan J Hue, Shreya Gupta, et al.Cancer Reports (Hoboken, N.J.)|July 10, 2021
The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysisKavin Sugumar, Jonathan J Hue, Solanus De La Serna, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2022
Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysisKavin Sugumar, Alex Hurtado, Ilora Naik, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 2, 2023
Understanding surgical attrition for "resectable" pancreatic cancerHanna Kakish, Jack Zhao, Fasih A Ahmed, et al.Journal of Pancreatic Cancer|May 3, 2021
Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic CancerJonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.The Journal of Surgical Research|December 23, 2023
Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract CancersMohamedraed Elshami, John B Ammori, Jeffrey M Hardacre, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 12, 2012
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 studyJeffrey M Hardacre, Mary Mulcahy, William Small, et al.Pageof 8